MarketPeel
Insider Trading Intelligence
RB

Richard J. Benjamin

CERS
CHIEF MEDICAL OFFICER · CERUS CORP · CIK 0001296322
FILING MIX · LIFETIME37%/63%
BUYS
34
SELLS
57
TOTAL VALUE
$6.85M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
777,361
AVG SELL PX
$4.34
TRADE KIND
SHOWING 91 / 91
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
32 backtested trades · 8 horizons · 21 pending
Forward-return performance of every backtestable P/S trade by Richard J. Benjamin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d32+71.88%-2.73%+0.51%-3.24%-3.25%-2.87
14d32+71.88%-1.81%+1.42%-3.23%-6.59%-1.83
30d32+78.13%-2.65%+1.56%-4.21%-6.83%-2.11
60d32+62.50%-0.50%+4.33%-4.83%-11.12%-1.16
90d32+71.88%+2.05%+5.76%-7.50%-15.88%
180d32(5 pending)+81.48%-8.01%+11.43%-19.44%-21.03%
1y32(5 pending)+70.37%-12.24%+19.77%-32.01%-37.71%
2y32(11 pending)+85.71%-31.53%+33.18%-64.71%-57.41%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CERS · 777,361 shares · as of Mar 12, 2026
0251,249502,498753,7461,004,995202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 34 buys / 57 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
101,740$1.66$168.6K777,361Mar 12, 2026Mar 16, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
40,426$1.88$76.0K879,101Mar 9, 2026Mar 9, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
40,426$1.88$76.0K879,101Mar 9, 2026Mar 10, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
24,235$2.01$48.6K919,527Mar 6, 2026Mar 9, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
24,235$2.01$48.6K919,527Mar 6, 2026Mar 10, 2026View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
55,2201,004,995Mar 5, 2026Mar 9, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
61,233$2.06$126.3K943,762Mar 5, 2026Mar 9, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
61,233$2.06$126.3K943,762Mar 5, 2026Mar 10, 2026View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
55,2201,004,995Mar 5, 2026Mar 10, 2026View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
264,000949,775Mar 2, 2026Mar 4, 2026View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
30,075$1.45$43.6K685,775Mar 14, 2025Mar 17, 2025View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
18,949$1.45$27.5K715,850Mar 13, 2025Mar 17, 2025View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
26,139$1.50$39.2K734,799Mar 7, 2025Mar 10, 2025View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
300,000694,373Mar 6, 2025Mar 10, 2025View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
66,565760,938Mar 6, 2025Mar 10, 2025View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
6,292$1.55$9.7K394,373Mar 4, 2025Mar 5, 2025View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
51,254$1.58$80.8K400,665Mar 3, 2025Mar 5, 2025View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
13,912451,919Mar 3, 2025Mar 5, 2025View →
CERS
CERUS CORP
SALE
Chief Medical Officer
13,9120Mar 3, 2025Mar 5, 2025View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
13,91213,912Feb 26, 2025Feb 28, 2025View →
CERS
CERUS CORP
SALE10b5-1
10b5-1 plan
21,605$2.50$54.0K438,007Aug 2, 2024Aug 7, 2024View →
CERS
CERUS CORP
SALE
Chief Medical Officer
17,738$1.97$35.0K459,612Mar 14, 2024Mar 14, 2024View →
CERS
CERUS CORP
SALE
Chief Medical Officer
17,377$2.06$35.7K477,350Mar 13, 2024Mar 14, 2024View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
16,666494,727Mar 12, 2024Mar 14, 2024View →
CERS
CERUS CORP
SALE
Chief Medical Officer
16,6660Mar 12, 2024Mar 14, 2024View →
CERS
CERUS CORP
SALE
Chief Medical Officer
29,378$2.40$70.5K478,061Mar 8, 2024Mar 12, 2024View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
160,000507,439Mar 1, 2024Mar 5, 2024View →
CERS
CERUS CORP
SALE
Chief Medical Officer
5,747$2.80$16.1K357,439Mar 13, 2023Mar 14, 2023View →
CERS
CERUS CORP
SALE
Chief Medical Officer
9,606$2.80$26.9K346,519Mar 13, 2023Mar 14, 2023View →
CERS
CERUS CORP
SALE
Chief Medical Officer
10,000$2.78$27.8K347,439Mar 13, 2023Mar 14, 2023View →
CERS
CERUS CORP
SALE
Chief Medical Officer
23,4600Mar 12, 2023Mar 14, 2023View →
CERS
CERUS CORP
SALE
Chief Medical Officer
16,66716,666Mar 12, 2023Mar 14, 2023View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
23,460356,125Mar 12, 2023Mar 14, 2023View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
16,667363,186Mar 12, 2023Mar 14, 2023View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
160,000332,665Mar 1, 2023Mar 3, 2023View →
CERS
CERUS CORP
SALE
Chief Medical Officer
10,000$5.12$51.2K172,665Aug 9, 2022Aug 11, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
5,982$5.04$30.1K182,665Mar 14, 2022Mar 15, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
8,173$5.04$41.2K171,980Mar 14, 2022Mar 15, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
16,152$5.04$81.4K157,383Mar 14, 2022Mar 15, 2022View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
16,667188,647Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
22,770180,153Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
16,66733,333Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
45,0000Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
22,77023,460Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
45,000173,535Mar 12, 2022Mar 15, 2022View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
105,000105,000Mar 1, 2022Mar 3, 2022View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
52,500128,535Mar 1, 2022Mar 3, 2022View →
CERS
CERUS CORP
SALE
Chief Medical Officer
33,3338,334Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
31,667$4.32$136.8K107,702Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
33,333$4.33$144.3K109,368Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
31,66731,667Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,000$7.90$790.0K76,035Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
100,000$4.72$472.0K176,035Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,0000Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
33,333$7.35$245.0K76,035Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
31,667$7.35$232.8K76,035Nov 3, 2021Nov 5, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
5,556$6.38$35.4K52,040Mar 15, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
15,786$6.38$100.7K81,254Mar 15, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
7,989$6.38$51.0K96,035Mar 15, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
20,000$6.34$126.8K76,035Mar 15, 2021Mar 16, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
45,00097,040Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
22,77046,230Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
45,00045,000Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
SALE
Chief Medical Officer
15,8330Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
15,83357,596Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
22,770104,024Mar 12, 2021Mar 16, 2021View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
100,000100,000Mar 1, 2021Mar 3, 2021View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
50,00050,000Mar 1, 2021Mar 3, 2021View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
100,000$4.72$472.0K141,763Aug 24, 2020Aug 26, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,000$7.90$790.0K41,763Aug 24, 2020Aug 26, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,000100,000Aug 24, 2020Aug 26, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
22,91725,000Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,000$7.20$720.0K41,763Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
22,917$4.33$99.2K64,680Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
31,666$4.32$136.8K73,429Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
22,917$7.20$165.0K41,763Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
100,000$4.72$472.0K141,763Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
100,000200,000Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
31,666$7.20$228.0K41,763Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
31,66623,750Jul 7, 2020Jul 9, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
45,00059,260Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
15,83320,311Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
3,022$3.59$10.9K4,478Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
6,051$3.59$21.8K14,260Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
17,497$3.59$62.9K41,763Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
PURCHASE
Chief Medical Officer
7,5007,500Mar 17, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
7,5000Mar 12, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
45,00090,000Mar 12, 2020Mar 24, 2020View →
CERS
CERUS CORP
SALE
Chief Medical Officer
15,83315,833Mar 12, 2020Mar 24, 2020View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
69,00069,000Mar 2, 2020Mar 16, 2021View →
CERS
CERUS CORP
PURCHASEGRANT
Stock grant
138,000138,000Mar 2, 2020Mar 16, 2021View →
Other insiders · CERS
Loading peer insiders…
About this filer
CIK 0001296322
ROLE
Chief Medical Officer
PRIMARY
CERS
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001296322DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback